Trial reportBMC geriatrics2026
Effects of a combined diet and physical activity intervention (the ALAPAGE program) on dietary diversity and lower-limb muscle strength in community-dwelling older people: a pragmatic randomized controlled trial.
Trial report in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05140330 (French Tittle), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
French Tittle : Recherche Visant à améliorer l'ALimentation et l'Activité Physique du Sujet AGE Vivant à Domicile - Etude ALAPAGE
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundDiet and physical activity are key components of healthy aging. We aimed to evaluate the effectiveness of a combined diet and physical activity intervention (the ALAPAGE program) in improving dietary diversity (proxy for the nutritional quality of individual diets) and lower-limb muscle strength (LLMS, a predictor of the ability to perform activities of daily living) among community-dwelling adults aged ≥ 60 years in France.
methodsThe ALAPAGE program comprised a 7-week intervention period with weekly collective sessions supervised by a dietician and/or a qualified physical activity professional, followed by 12 weeks of unsupervised activity. Its effectiveness was assessed through a cluster-randomized controlled trial conducted in 2022-2024. Clusters of groups of approximately 10 participants were allocated to either an intervention arm or a control arm (2:1 ratio). Primary outcomes were (1) dietary diversity assessed with the ORCHID score (each assessment based on two 24-hour dietary recalls and a simplified food frequency questionnaire), and (2) LLMS, assessed by the 30-second chair stand test. Assessments were conducted at baseline (T0), 7 weeks (T1, dietary diversity only), and 3 months (T2). A difference-in-difference (D-I-D) analysis, adjusted for covariables, was used to evaluate the specific impact of the intervention over time, compared to the control arm.
resultsThe analysis included 376 participants: 254 (26 clusters) in the intervention arm and 122 (12 clusters) in the control arm. At baseline, the ORCHID score and LLMS did not differ significantly between the two arms. The ORCHID score improved significantly with time in both arms (intervention: +10% and + 16% increase at T1 and T2 respectively, control: +4% and + 11%) with no significant difference between the arms. LLMS improved between T0 and T2 in both arms (intervention: +15%; control: +5%), with a statistically significantly greater increase of 1.3 chair stands over 30 s in the intervention vs. the control arm (P = 0.005).
conclusionWhile dietary diversity improved similarly in both arms, the intervention-specific improvement in LLMS - a parameter associated with functional capacity - suggests the ALAPAGE program has potential as a preventive public health approach for contributing to healthy aging in community-dwelling older adults.
trial registrationClinicalTrials.gov Identifier: NCT05140330, November 4, 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.